Evidence on Diabetes Management
Here is a collection of evidence and resources on the topic of diabetes management to help decision-makers — from health care professionals to consumers — make evidence-based decisions on diabetes treatment.
We've selected the following materials to get you started:
- Real-Time Continuous Glucose Monitoring: A Review of Guidelines (Rapid Review, October 24, 2022)
- Real Time Continuous Glucose Monitoring for People Living with Type 2 Diabetes (Rapid Review, September 28, 2022)
- Real-Time Continuous Glucose Monitoring for People Living With Type 1 Diabetes (Rapid Review, August 22, 2022)
- Intranasal Glucagon for the Treatment of Hypoglycemia (Summary With Critical Appraisal, June 24, 2022)
- Tirzepatide for Type 2 diabetes mellitus (Emerging Health Technologies, Apr 26, 2022)
In this Bundle
-
Topical Wound Oxygen Therapy for Wound Healing: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines
(Summary with Critical Appraisal, July 17, 2020)
-
Off-Loading Devices for People with Diabetic Neuropathic Foot Ulcers: A Rapid Qualitative Review
(Summary with Critical Appraisal, June 17, 2020)
-
human insulin
To improve glycemic control in adults and children with diabetes (Reimbursement Review)
-
Hybrid Closed-Loop Insulin Delivery Systems for People with Type 1 Diabetes
(Optimal Use, June 23, 2021)
-
insulin degludec + liraglutide
For diabetes mellitus, type 2 (Reimbursement Review)
-
ertugliflozin and metformin
For diabetes mellitus, type 2 (Reimbursement Review)
-
lixisenatide + insulin glargine
For diabetes mellitus, type 1 & 2 (Reimbursement Review)
-
insulin degludec
For diabetes mellitus, type 1 & 2 (Reimbursement Review)
-
Real-Time Continuous Glucose Monitoring: A Review of Guidelines
(Summary with Critical Appraisal, October 24, 2022)
-
Real Time Continuous Glucose Monitoring for People Living with Type 2 Diabetes
(Rapid Review, September 28, 2022)
-
Real-Time Continuous Glucose Monitoring for People Living With Type 1 Diabetes
(Rapid Review, August 22, 2022)
-
Intermittently Scanned and Real-Time Continuous Glucose Monitoring for People With Diabetes
(Rapid Review, July 6, 2022)
-
Flash Glucose Monitoring Systems in Pediatric Populations with Diabetes
(Summary with Critical Appraisal, April 6, 2021)
-
faricimab
(Report, January 13, 2023)
-
Multiple Prosthetic Sockets for Lower Limb Amputations
(Rapid Review, July 21, 2022)
-
Removable Rigid Dressings for the Post-Operative Management of Leg Amputations
(Summary with Critical Appraisal, June 27, 2022)
-
Intranasal Glucagon for the Treatment of Hypoglycemia
(Summary with Critical Appraisal, June 24, 2022)
-
Islet Cell Transplantation for Patients with Unstable or Uncontrollable Diabetes Mellitus: Clinical Effectiveness. Cost-Effectiveness and Guidelines
(Summary with Critical Appraisal, May 4, 2020)
-
glucagon
For severe hypoglycemic reactions (Reimbursement Review)
-
fluocinolone acetonide intravitreal implant
For diabetic macular edema (Reimbursement Review)
-
dexamethasone
For diabetic macular edema (Reimbursement Review)
-
semaglutide
For diabetes mellitus, type 2 (Reimbursement Review)
-
semaglutide
For diabetic macular edema (Reimbursement Review)
-
Tirzepatide for Type 2 diabetes mellitus
(Emerging Health Technologies, April 26, 2022)
-
Pioglitazone for Type 2 Diabetes Mellitus and Pre-Diabetes: A Review of Safety
(Summary with Critical Appraisal, June 22, 2020)
-
Reimbursement Status of Newer Drugs for the Treatment of Type 2 Diabetes
(Environmental Scan, February 27, 2019)
-
ertugliflozin
For diabetes mellitus, type 2 (Reimbursement Review)
-
ertugliflozin and metformin
For diabetes mellitus, type 2 (Reimbursement Review)
-
Dapagliflozin
For diabetes mellitus, type 2 (Reimbursement Review)
-
lixisenatide
For diabetes mellitus, type 2 (Reimbursement Review)
-
Drugs for Type 2 Diabetes: Second-Line Therapy Review Update
Short on time? Read the In Brief.
-
Real-Time Continuous Glucose Monitoring for People Living With Diabetes
(Tools, December 22, 2022)
-
Developments in diabetes management: What do we know about tirzepatide?
(Hospital News article, July 2022)